Mercer Global Advisors’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
Mercer Global Advisors's CRDF Position: Q3 2026 in Review
Mercer Global Advisors sold out of Cardiff Oncology (CRDF) in Q3 2026, closing a stake of 12,755 shares — an estimated $16.6K sold.
Mercer Global Advisors first reported a position in CRDF in Q2 2020 and held it in 12 quarters. The position peaked at $2.44M in Q4 2020. 75 funds tracked by Wall St. Rank hold CRDF as of Q3 2026.
- Mercer Global Advisors reported no remaining Cardiff Oncology position as of Q3 2026 after selling out during the quarter.
- Mercer Global Advisors sold 12,755 Cardiff Oncology shares in Q3 2026, an estimated $16.6K.
- Mercer Global Advisors first reported a position in Cardiff Oncology in Q2 2020 and held it in 12 quarters.
- Mercer Global Advisors's Cardiff Oncology position peaked at $2.44M in Q4 2020.
- 75 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.